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Abstract
N-myc downstream-regulated gene 1 (NDRG1) is induced by cellular stress such as hypoxia and DNA damage, and in
humans, germ line mutations cause Charcot-Marie-Tooth disease. However, the cellular roles of NDRG1 are not fully
understood. Previously, NDRG1 was shown to mediate doxorubicin resistance under hypoxia, suggesting a role for NDRG1
in cell survival under these conditions. We found decreased apoptosis in doxorubicin-treated cells expressing NDRG1
shRNAs under normoxia, demonstrating a requirement for NDRG1 in apoptosis in breast epithelial cells under normal
oxygen pressure. Also, different cellular stress regimens, such as hypoxia and doxorubicin treatment, induced NDRG1
through different stress signalling pathways. We further compared expression profiles in human breast epithelial cells
ectopically over-expressing NDRG1 with cells expressing NDRG1 shRNAs in order to identify biological pathways where
NDRG1 is involved. The results suggest that NDRG1 may have roles connected to vesicle transport.
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Introduction
N-myc downstream-regulated gene 1 (NDRG1) is also known as
Drg-1 (differentiation-related gene 1) [1], Cap43 (p43 protein
induced by free intracellular Ca2+) [2], and RTP (reducing agents
and tunicamycin-responsive protein) [3], named by its perceived
functions in different in vitro assays. The NDRG gene family
contains NDRG1, -2, -3 and -4, which have 57–65% amino acid
sequence identity [4]. The tissue-distribution of NDRG1 mRNA is
widespread [4,5], and the NDRG1 amino acid sequence is .80%
identical in a variety of species, ranging from amphibians and fish
to mammals [6]. However, the physiological functions of NDRG1
remain elusive. NDRG1 encodes a protein that belongs to the a/b
hydrolase superfamily, but lacks an apparent hydrolytic catalytic
site [7]. NDRG1 has been shown to exist as a multi-phosphor-
ylated protein, lacks an ER-targeting signal-sequence and has no
apparent transmembrane domain [3,8]. The protein has primarily
been detected in the cytoplasm, but is also seen associated with the
plasma membrane, nucleus and the inner mitochondrial mem-
brane, depending on the cell type assessed [5].
NDRG1 missense mutations cause hereditary motor and sensory
neuropathy-Lom (HMSNL), an autosomal recessive form of
Charcot-Marie-Tooth disease (CMT) also called CMT4D [9].
Patients with CMT4D exhibit early-onset peripheral neuropathy,
which progresses in adulthood to severe disability characterized by
muscle weakness, sensory loss, and neural deafness [9,10]. A
tumor-promoting role has also been reported for NDRG1 [11,12],
and it has been implicated in metastasis suppression [13–15].
Further, NDRG1 has been shown to have a role in myelin sheath
maintenance [9,16], exocytosis in mast cells [8,17], differentiation
[1,13,18], and NDRG1 expression is induced by homocysteine
[3], androgen [19], as well as in response to various forms of
cellular stress such as hypoxia [5,20,21], heavy metals [20] or
DNA damage [22,23].
In the present study, we induced DNA damage by doxorubicin
treatment of epithelial cell lines expressing NDRG1 at relatively
high (SUM102, ME16C2 and HCT116) or low (ZR-75-1 and
MCF-7) levels. We found that doxorubicin-induced apoptosis was
inhibited in epithelial breast cells expressing shRNAs targeting
NDRG1, demonstrating that NDRG1 is required for apoptosis in
these cells under normoxic conditions. We also present results
showing that NDRG1 is not a regulator of hypoxia-induced gene
expression in the epithelial cells studied, and that hypoxia and
doxorubicin treatment initiate different NDRG1 responses. Global
gene expression analysis of cell lines with manipulated NDRG1
expression demonstrates that NDRG1 influences the expression of
genes related to vesicular structures and transport. The roles of
NDRG1 in cellular responses to stress, such as hypoxia and
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apoptosis may converge by NDRG1 exerting its functions at the
level of endomembrane structures.
Results
NDRG1 does not Regulate Hypoxia-induced Gene
Expression
We first studied the two luminal breast cancer cell lines, ZR-75-
1 and MCF-7, and demonstrated increased NDRG1 expression
when these cells were grown at 1% O2 for 24 hours (Figure 1A).
Then we grew both cell lines under hypoxic conditions for 24 or
48 hours and compared the global gene expression profile with
cells grown at normoxia. Five microarrays were used per cell line
(Figure 1C). Sixteen out of 18 genes in a robust hypoxia signature
previously described by Chi et al. [24] showed increased expression
on the microarrays (Figure 1C), documenting the hypoxia
response in the cells analyzed.
We further investigated whether ectopic NDRG1 expression
would result in similar gene expression changes as those detected
in cells grown under hypoxic conditions. To facilitate ectopic
expression, a construct carrying NDRG1 cDNA (see Figure S1)
was transduced into ZR-75-1 in parallel experiments resulting in
six cell populations, ZR-75-1/NDRG1 A–F, all showing increased
NDRG1 expression (Figure 1B). Global gene expression profiling
was performed using the six ZR-75-1 cell populations ectopically
expressing NDRG1 grown in 20% O2 (9 microarrays) (see
experimental procedures for details). A one class significance
analysis of microarrays (SAM) was performed to identify genes
with similar expression patterns on these 9 microarrays and the 5
microarrays from ZR-75-1 cells grown under hypoxia. Only genes
represented on more than 60% of the arrays were included. The
SAM analysis identified only 6 genes in addition to NDRG1:
AGMAT, FTL, KLF12, LMNB1, SCHIP1, and STAT3 (FDR=0),
documenting a limited overlap in the global gene expression
response when NDRG1 is induced by hypoxia compared to
ectopic NDRG1 over-expression. Furthermore, the only gene in
the hypoxia signature showing increased expression in the cells
ectopically expressing NDRG1 was NDRG1 itself (Figure 1D).
Thus, ectopic over-expression of NDRG1 does not trigger a gene
expression profile resembling the hypoxic response, showing that
NDRG1 is not itself a regulator of hypoxia-induced gene
expression in the cells analyzed.
DNA Damage and Hypoxic Growth Induce different
NDRG1 Responses in the Cell
NDRG1 has previously been shown to have a role in TP53-
mediated apoptosis in colon and pancreatic cell lines [25,26]. We
detected increased TP53 levels and a distinct increase in NDRG1
levels in a panel of doxorubicin treated cells (Figure 2A).
Furthermore, we detected a significantly reduced fraction of
apoptotic cells when NDRG1 shRNAs [27] were expressed in the
immortalized breast cell line SUM102 (Figure 2B). This shows
that NDRG1 is necessary for doxorubicin-induced apoptosis in
SUM102 under normoxic conditions.
We then treated SUM102 cells with doxorubicin and in parallel
grew cells in hypoxic conditions, and used immunofluorescence to
detect NDRG1 (Figure 3A). Cells grown at 1% O2 show
increased NDRG1 levels in the cytoplasm, whereas doxorubicin
treatment resulted in increased NDRG1 levels with a coarsely
granulated cytoplasmic staining pattern (Figure 3A). Staining
with markers for ER (calnexin) and early endosomes (EEA1) did
not show co localization with NDRG1 in SUM102 under the
conditions tested (Figure 3A,B). Furthermore, we did not observe
any obvious morphological differences in the SUM102 cells with
or without NDRG1shRNA expression under the conditions tested
(results not shown). In summary, our results indicate that hypoxia
and doxorubicin treatments initiate different NDRG1 responses in
SUM102 cells.
Figure 1. Increased NDRG1 expression due to hypoxia or
ectopic expression. (A) Increased NDRG1 expression detected by
Western blotting in the breast cell lines MCF-7 and ZR-75-1 grown at 1%
O2 for 24, 48 and 72 hours as indicated, compared to control cells
grown at 20% O2. (B) Western blots document increased NDRG1
expression in cells grown at 20% O2. The ZR-75-1 cell populations
transduced with the NDRG1-cDNA (six biological parallels indicated A–
F), are compared to ZR-75-1 transduced with the vector pSiRPG [27]
without insert (C2 and C3). a-tubulin was used as loading control (A
and B). Note that a reduced level of total protein is loaded in the lane
containing extract from MCF-7 grown at 1% O2 for 24 hours. (C)
Treeview presentation of the expression of 18 genes in a hypoxia
signature gene list [24] in MCF-7 and ZR-75-1 cells grown at 1% O2 for
24 or 48 hours as indicated. (D) Treeview presentation of the hypoxia
signature genes in six ZR-75-1 cell populations ectopically over-
expressing NDRG1 (indicated A–F). The red and green colours show
increased and reduced expression levels, respectively (C and D). The
colour intensity is from 23 to 3 indicating the magnitude of the fold
change in gene expression between the cell population and its control.
doi:10.1371/journal.pone.0087268.g001
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Global Gene Expression Analysis Indicate that NDRG1
Function is Connected to Endomembrane Structures and
Vesicular Transport
To investigate the global gene expression changes caused by
manipulated NDRG1 expression, we focused on the breast
epithelial cell lines SUM102 and ME16C2, because both have
high endogenous NDRG1 expression (Figure 4). Two NDRG1
shRNA constructs, NDRG1si4 and NDRG1si7 [27], were
transduced into these cell lines in two parallel experiments
resulting in a total of eight cell populations with reduced NDRG1
expression: SUM102/NDRG1si4A and 4B, SUM102/
NDRG1si7A and 7B, ME16C2/NDRG1si4A and 4B, and
ME16C2/NDRG1si7A and 7B (Figure 4). Global gene expres-
sion profiling was performed and a two class SAM analysis was
used to identify genes showing different expression in SUM102
and ME16C2 with NDRG1 knock-down (16 microarrays)
compared to ZR-75-1 ectopically over-expressing NDRG1 (9
microarrays). The SAM delta value was adjusted to obtain the
largest gene list that gave a false discovery rate of less than 5%
identifying 103 probes representing 83 genes (FDR=3.5%) (table
S1). The remaining probes represented control oligos, duplicated
oligos and multiple oligos targeting the same gene. Clustering of
the resulting 83 genes identified across the different cell
populations are visualized in Figure 5.
Functional information was available for 69 of the 83 genes in
the SAM-derived gene list and these were used to search for
enriched gene ontology terms by Gominer [28]. The cellular
compartments identified in the Gominer analysis using a cutoff for
significant GO categories at p#0.005, are listed in table S2;
vesicle coat (3 genes), organelle membrane (13 genes), extracellular
space (10 genes), membrane coat (3 genes), integral to organelle
membrane (4 genes), and endoplasmic reticulum (11 genes), in
total adding up to 26 of the 69 genes (as several of the genes are
present in more than one category). Motivated by the Gominer
results, we further reviewed the literature regarding the remaining
genes in the SAM-derived gene list. The products from an
additional 8 genes were found to be involved in ER to Golgi, Golgi
to ER or endosomal transport, and 2 were found to be involved in
endocytosis and exocytosis. In summary, of the 69 genes with
functional information in the SAM-derived gene list, a total of 21
genes were shown to be involved in processes connected to vesicle
transport (indicated in orange in Figure 5). Nineteen of these 21
genes showed an opposite expression pattern compared to
NDRG1; i.e. they were up-regulated in the cell populations where
the NDRG1 level was reduced by shRNAs, and down-regulated in
ZR-75-1 with ectopic NDRG1 expression (indicated in orange in
Figure 5). These results suggest that induced changes in NDRG1
expression affect the expression of genes involved in vesicle
transport.
Discussion
NDRG1 Exerts its Effect through Different Stress-
signalling Pathways
Hypoxic stress has been shown to induce NDRG1 expression in
a variety of cells [29], but NDRG1’s roles during hypoxia are not
fully understood. We identified a similar expression pattern of only
seven genes, including NDRG1, when comparing the global gene
expression profile in ZR-75-1 cells grown under hypoxia with cells
ectopically over-expressing NDRG1. Thus, NDRG1 does not act
as a sensor of intracellular oxygen tension. The elevated NDRG1
expression is rather a secondary effect of hypoxic stress.
NDRG1 is induced both by ectopically expressed and
endogenously increased TP53, the NDRG1 promoter contains a
putative TP53 binding site [25,30], and NDRG1 has been shown
to be necessary for TP53-dependent apoptosis in colon and
pancreatic cells [25,26]. In line with this, we detected decreased
apoptosis in doxorubicin-treated breast epithelial cells expressing
NDRG1 shRNAs under normoxia. Other studies show no
correlation between NDRG1 expression and apoptosis despite
the up-regulation of TP53 [15,21,30,31], suggesting different
responses depending on the cell types and conditions studied. Jung
et al. [32] demonstrated that hypoxia-induced NDRG1 expression
can mediate doxorubicin resistance, suggesting that NDRG1
might increase cellular survival under hypoxia. We observed
strongly elevated NDRG1 levels under hypoxia and in cells
subjected to acute DNA-damage by doxorubicin treatment. Under
hypoxia we detected an even cytoplasmic NDRG1 signal, whereas
doxorubicin treatment resulted in a granulated signal. NDRG1
did not co-localize with ER or early endosomes under the
conditions tested. Our results are consistent with the report by Shi
et al. [33], who detected NDRG1 at the cell membrane and the
cytoplasmic network closely associated with the ER in trophoblasts
under hypoxia. Our observations are in agreement with NDRG1
exerting its functions through different stress-signalling pathways,
resulting in increased cell survival under hypoxia, while being
permissive for doxorubicin-induced apoptosis under normoxic
conditions.
Global Gene Expression Analysis Links NDRG1 to
Endomembranes and Vesicular Transport
Several of the genes identified in the current global expression
profiling encode proteins located in the ER (NFE2L3, ASPHD1,
Figure 2. Silencing of NDRG1 inhibits apoptosis in the SUM102
cell line. (A) Western blots detect increased TP53 and NDRG1
expression in HCT116, MCF-7, ZR-75-1 and SUM102 cells after treatment
with doxorubicin (1 mM) for 24 hours (+) compared to control cells (2).
a-tubulin was used as loading control. (B) The percentage of apoptotic
cells detected by TUNEL assay in the SUM102/pSiRPG, SUM102/
NDRG1si4A and SUM102/NDRG1si7A cell lines after treatment with
doxorubicin (1 mM) for 24 hours as indicated. Bars are shown with 95%
confidence intervals (p,0,02, unpaired two-tailed t-test).
doi:10.1371/journal.pone.0087268.g002
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CKAP4, HSD17B2, TMPRSS3, KSR1 and RDH16), proteins
required for endosome to Golgi trafficking (ARL1), for transport
through Golgi (GOLM1), for the retrograde Golgi-to-ER transport
(COPE), and for vesicle budding from the ER (SEC24D). The
microarray results also revealed genes encoding proteins involved
in the targeting of proteins to the ER (SRP54), ER membrane
translocation (SSR3), and proteins needed for chaperone function
(DNAJC12 and TMEM132A). Previous studies have suggested that
NDRG1 might be a client protein of the chaperone HSP90, or
that NDRG1 is a chaperone protein itself [19]. In our microarray
experiments we detected CD47 and NECAP1, the latter inhibits
endocytosis when over-expressed [34], and CD47 trigger exocy-
tosis when activated [35,36]. In total, 21 of the 69 differently
expressed genes detected in the gene expression profiling in cells
with manipulated NDRG1 expression encode proteins that are
linked to ER, Golgi, endosomes or vesicular transport between
these compartments (indicated in orange in Figure 5). Nineteen
of these 21 genes are up-regulated in cell populations with
NDRG1 knock down, and down-regulated in cell populations with
ectopic over-expression of NDRG1, which indicates that NDRG1
facilitates a down-regulation of several genes encoding proteins in
the ER to endosome axis. In stressful situations with lack of energy,
such as under hypoxia or during ER-stress, a down-regulation of
some activities in the secretory and/or endocytic routes of the cell
might conserve energy and thus contribute to restore cellular
homoeostasis. It is tempting to speculate that NDRG1 might
increase cell survival during hypoxia through such a mechanism.
CDC42 belongs to the Rho family of GTPases and influences
vesicle trafficking at many levels, anterograde ER to Golgi, post-
Golgi, exocytosis as well as endocytosis and further retrograde
transport via interaction with Wiskott-Aldrich syndrome protein
(N-WASP) and the Arp2/3 complex leading to altered actin
dynamics [37–39]. Three of the genes detected in our microarray
analysis, CDC42EP, DOCK11 and ARHGEF16 encode proteins
that modulate the activity of CDC42: While CDC42EP negatively
regulates CDC42 function, both DOCK11 and ARHGEF16
Figure 3. Immunofluorescence staining of SUM102 cell cultures. Colors were applied artificially for graphical purposes. (A) NDRG1 (green)
and calnexin (red) in untreated, hypoxia and doxorubicin treated cells. Bar: 5 mm. (B) NDRG1 (green) and EEA1 (red) in hypoxia treated cells. Bar:
10 mm.
doi:10.1371/journal.pone.0087268.g003
Figure 4. Knock down of NDRG1 expression by shRNAs. Western
blots detect reduced NDRG1 expression in the breast cell lines ME16C2
and SUM102 expressing the shRNAs NDRG1si4 (si4) and NDRG1si7 (si7),
transduced in parallel experiments (A and B) compared to control cells
(C) transduced with the empty vector pSiRPG [27]. a-tubulin was used
as loading control.
doi:10.1371/journal.pone.0087268.g004
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specifically activate CDC42 [40–43]. In cells over-expressing
NDRG1, the levels of CDC42EP, DOCK11 and ARHGEF1
detected on the micro arrays are shifted in a direction that is in
agreement with an induction of increased CDC42 activity,
conceivably resulting in increased vesicle trafficking. Thus,
NDRG1 may indirectly play a role in vesicle trafficking and in
maintenance of cellular polarity, by stimulating CDC42. Interest-
ingly, hyperactivation of CDC42 can contribute to cellular
transformation and tumor invasion and metastasis, through
generation of plasma membrane protrusions, so-called invadopo-
dia [39]. Further investigations are needed to clarify the putative
interplay between NDRG1 and CDC42 signalling pathways.
In humans, Alaskan Malamute and Greyhound, germline
NDRG1 mutations cause the demyelinating disorder CMT4D
[9,44] and Ndrg1 deficient mice show defects connected to myelin
sheath maintenance [16,45]. Generally, many genes affected in
Charcot-Marie-Tooth disease include proteins involved in regu-
lation of endocytosis and vesicle transport [46–48]. In a study of an
early onset demyelinating disease, classified as CMT4H in one
Lebanese and one Algerian family, Delague and colleagues [49]
identified novel mutations in a protein directly influencing the
activity of CDC42. The protein, known as FRABIN (FGD1-
related F-actin binding protein) is a specific regulator of CDC42
activity and it was postulated that the mutations led to loss of
CDC42 activity, leading to reduced F-actin positive filipodia
protrusions in cell cultural experiments. Whether CDC42 activity
is compromised also in CMT4D, due to NDRG1 inactivation, is
presently unknown, and might thus provide a starting-point for
further studies into the molecular pathogenesis of CMT4D.
Recently, cell death signals have been shown to induce
trafficking of recycling endosomes through a pathway involving
CDC42 [50], and CDC42 was shown to be involved in FAS-
enhanced membrane trafficking [51]. Also, TP53 can induce
apoptosis through death receptors by increased expression of FAS
[52]. NDRG2 silencing has been shown to inhibit TP53-mediated
apoptosis [53], and inactivation of NDRG2 may elicit resistance
against FAS-mediated cell death [54]. Our microarray results may
indicate an involvement of NDRG1 in trafficking of recycling
endosomes. Additional research is required to explore if increased
NDRG1 levels could result in TP53-mediated apoptosis through
increased vesicle formation, internalization and recycling of FAS
through activation of CDC42. Furthermore, the reported tumor-
promoting role of NDRG1 [11,12] and the role in metastasis
suppression [13–15], which are apparently contradictory may be
explained by involvement of NDRG1 both in cell survival under
hypoxia and in doxorubicin-induced apoptosis under normoxia. In
summary, the pleotropic roles of NDRG1 reported in apoptosis,
cell survival, myelin sheath maintenance and enhanced exocytosis
in mast cells, and in the cellular responses to hypoxia, heavy
metals, and androgenes may converge by NDRG1 influencing
vesicular trafficking.
Materials and Methods
Cell Culture and Generation of Stable Cell Populations
The breast epithelial cell lines ME16C2 [55], and SUM102, a
gift from Steve Ethier of Wayne State University (Asterand, MI,
USA), and their derivatives were grown in TCF-EGM developed
by the Tissue Culture Facility at the University of North Carolina
at Chapel Hill (http://www.unclineberger.org/tcf/index.asp).
Figure 5. Gene expression profile of cells with manipulated
NDRG1 expression. Treeview presentation of the 83 probes
representing genes found to be significantly differently expressed in
SUM102 and ME16C2 cells expressing NDRG1 shRNAs when compared
to ZR-75-1 with ectopic NDRG1 over-expression. The results show a
hierarchical clustering of the gene expression pattern, while the arrays
are sorted according to cell populations. Genes with no available
functional information (14 genes) are indicated with (*). Genes
annotated in orange encode proteins that are linked to ER, Golgi,
endosomes, as well as genes connected to vesicle transport. The
expression of NDRG1 (black) confirms the ectopic over-expression in
ZR-75-1 and shRNA-based down-regulation in SUM102 and ME16C2
cells. The red and green colours show over-expression and down-
regulation respectively. The colour intensity varies between 22 and 2
indicating the magnitude of the fold change in gene expression
between the cell population and its control.
doi:10.1371/journal.pone.0087268.g005
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The luminal breast cancer cell lines ZR-75-1 (CRL 1500; ATTC,
Manassas, VA, USA) and MCF-7 (HTB-22; ATTC) and their
derivatives were grown in RPMI1640 with phenol red (Lonza,
Walkersville, MD, USA) supplemented with 2 mM L-glutamine
(Invitrogen, Carlsbad, CA, USA) and 10% FBS (Invitrogen).
HCT116 (CCL-247; ATTC) was grown in McCoy’s 5a medium
(Lonza) supplemented with 10% FBS. For the hypoxia experi-
ments cells were grown in a hypoxic chamber, MIC-101, (Billups-
Rothenberg, Del Mar, CA, USA) at 1% O2.
Transductions were performed as previously described [27].
Stably transduced cell populations were established by selection
with puromycin (2 mg/mL; Invitrogen) for 2–5 weeks. All cell
populations were analyzed by Western blotting for expression of
NDRG1. Cell populations transduced with the vector pSiRPG
[27] without insert were also created as controls.
Western Blotting
Cells harvested in PBS were lysed in M-PER (Thermo Fisher
Scientific, Rockford, IL, USA) containing Halt Protease Inhibitor
and 5 mM EDTA (Thermo Fisher Scientific). Protein concentra-
tions were quantified using a NanoDropH ND-1000 Spectropho-
tometer (Thermo Scientific, Wilmington, DE, USA) or with a dye-
binding assay (Bio-Rad, Hercules, CA, USA. Protein electropho-
resis, western blotting and immunodetection were performed as
previously described [27]. The blots were incubated over night
with the NDRG1 antibody (diluted 1:1000; Clarient, Aliso Viejo,
CA, USA). A monoclonal a-tubulin antibody (diluted 1:1000;
SIGMA Aldrich, St. Louis, MO, USA) was used as loading
control. Secondary antibody was horseradish peroxidase-conju-
gated anti-rabbit or anti-mouse, respectively (diluted 1:5000; GE
Healthcare, Buckinghamshire, United Kingdom), which was
detected by enhanced chemiluminescence (ECL Plus, GE
Healthcare). Blots in Figure 1 were visualized with alkaline
phosphatase-conjugated secondary antibodies (Bio-Rad) and
fluorescence was recorded with a variable mode imager (Typhoon
9200, GE Healthcare).
Global Gene Expression Analysis
Total RNA was isolated from all cell populations using
RNAeasy (Qiagen, Hilden, Germany). Cells grown under hypoxic
conditions (24 h and 48 h) and control cells incubated at normoxia
were harvested in lysis buffer at the same time points. RNA was
labeled with Cy3- or Cy5-CTP [56]. To minimize the dye effects,
three of the cell populations, ZR-75-1/NDRG1 A/B/C, were
labeled with both Cy3- and Cy5-CTP and mixed with the control
RNA labeled with the opposite dye. The three remaining ZR-75-1
populations were labeled once, but population E was labeled with
the opposite dyes compared to population D and F. For ZR-75-1
and MCF-7 grown under hypoxia, all parallels were labeled once,
but two of the parallels harvested after 48 hours were labeled with
the opposite dyes compared to the other samples. For the cell
populations expressing shRNAs, each sample was labeled with
both dyes in a dye flip set-up. Samples were hybridized to either
Human 1A (V2) Oligo Microarrays (G4110B) or Human Whole
Genome Oligo Microarrays (G4112A) (Agilent, Santa Clara, CA,
USA). Scanning were performed using a GenePix 4000B scanner
(Molecular Devices, Sunnyvale, CA, USA) adjusting the PMT
settings for each channel and each array so that the count ratio
was close to 1 and the intensities of the spots did not exceed the
maximum detection limit. Image analysis was performed using
GenePix Pro 6 (Molecular Devices). Loess Normalization was
performed to adjust microarray data for variation between the
samples.
All microarray data reported in this paper is MIAME compliant
and the raw data has been deposited in the GEO database (GEO
accession number GSE33439).
Statistical Analysis
Both one class and two class SAM (SAM version 3.02) was
performed using 100 permutations and 10 k-nearest neighbors
[57]). The SAM delta value was adjusted to give a false discovery
rate (FDR) less than 5%. The SAM derived gene lists were
clustered using the average linkage hierarchical cluster analysis in
the Cluster program [58] sorted on samples, and the data were
visualized in Treeview [59]. The SAM derived gene list was
analyzed for the cellular component gene ontology using High-
Throughput GoMiner [60]. All genes represented on the
microarray were entered as a background file. A one sided p-
value was calculated for each category based on a Fishers exact
test. The threshold of significance for a category was defined as
p#0.05.
Measuring Apoptosis by TUNEL Assay
SUM102 seeded at 200.000 cells per cm2 adhered for 24 h
before treatment with doxorubicin (1 mM; Sigma-Aldrich) for 24
hours. Duplicates were harvested and washed twice with PBS and
fixed in 4% paraformaldehyde in PBS for 15 min at 4uC. Cells
were pelleted by centrifugation and permeabilized in pure
methanol for at least 20 min at 220uC. The cells were washed
twice with PBS and apoptotic cells detected by terminal
deoxynucleotidyl transferase mediated dUTP end-labeling (TU-
NEL) assay using the In situ cell death detection kit, Fluorescein
(Roche Applied Science, Mannheim, Germany). The cells were
incubated for 60 min at 37uC with TdT and fluorescein,
centrifuged and stained with Hoechst 33258 (2 mg/ml; Invitrogen)
for 15 min on ice. The cells were filtered through a nylon mesh
and 10000 events were analyzed for each sample using FACS
DIVa Vantage Cell Sorter (Becton Dickinson, Heidelberg,
Germany) and data collection carried out using the CellQuest
3.3 software (BD Biosciences, Franklin Lakes, NJ, USA).
Immunofluorescence
SUM102 cells were plated on glass chambered slides and grown
to 60–80% confluence. The cells were fixed in 2% paraformal-
dehyde in PBS, washed and treated with 0.2% Triton X-100 in
PBS for permeabilization. After blocking (2% BSA, 0.2% Tween
20, 7% Glycerol, 2% Goat serum, in PBS), cells were incubated
with NDRG1 antibody (rabbit, diluted 1:200; Clarient) or isotype
control antibodies (Invitrogen) over night. Secondary antibody was
Alexa-405 anti-rabbit (diluted 1:250; Invitrogen A31556). Early
endosomes were marked with the EEA1- antibody (mouse
monoclonal IgG1 diluted 1:1000; Abcam ab70521), and detected
with secondary anti-mouse IgG1 antibody Alexa-633 (dilut-
ed1:1000; Invitrogen A21126). Endoplasmic reticulum was
marked with an anti-calnexin antibody (mouse monoclonal
IgG1, diluted 1:1000; Abcam ab31290) and secondary anti-mouse
IgG1 antibody Alexa-488 (diluted 1:200; Invitrogen). Propidiu-
miodide (PI), was used in a 1:10 dilution for nuclear contrast.
Images were acquired using a Zeiss LSM 710 confocal laser
scanning microsope (Carl Zeiss, Jena, Germany). Lasers and
fluorescent filters were optimized for 405 nm (NDRG1), 488 nm
(calnexin), 560 nm (PI), and 633 nm (EEA1) excitation maxima.
To facilitate signal interpretation, pseudocolors were applied
digitally, using the Zen Lite 2011 software package (Carl Zeiss,
Jena, Germany). The aquired images were assembled in Adobe
Photoshop Elements 10 (Adobe Systems Inc., San Jose, California,
USA).
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Accession Number
The micro array results reported in this paper have been
assigned the GEO accession number GSE33439.
Supporting Information
Figure S1 The expression vector pRTRex. The vector pRTRex
is compatible with the Gateway system where the cDNA replaces
the fragment between the attR-sites using the LR clonase
(Invitrogen, CA, USA). The phosphoglycerate kinase (PGK) and
Cytomegalovirus (CMV) promoters are shown with open arrows.
The puromycin resistance gene (PuroR) and the Long terminal
repeats (LTR) from murine stem cell virus are shown as black
arrows. The vector is based on a pUC vector backbone for high
copy number propagation in E. coli. The map was constructed by
using Vector NTI (Invitrogen). The pRTRex vector was
constructed as follows; the plasmid pSUPER.retro.Puro (OligoEn-
gine, WA, USA) was digested with EcoRI and XhoI, and pT-Rex-
DEST30 (Invitrogen) was digested with NheI and PciI. The 59-
overhangs created by these enzymes were blunt ended with the
Klenow fragment of DNA polymerase 1 (New England Biolabs
(NEB), MA, USA). The resulting two fragments were religated,
transformed into into E.coli DH5a and colonies were analyzed by
restriction mapping and by sequencing over the cloning junctions
using the primers pTRexS1 (CCC CTT GAA CCT CCT CGT
TC) and pTRexS2 (GCC AGA GGC CAC TTG TGT AG). A
clone with the correct sequence was named pRTRex. This
Gateway compatible expression vector is available upon request. A
construct named pRTRex-NDRG1 contains the NDRG1 cDNA
insert (MGC-11293, ATCC-LGC), which was transferred via
pDONR201 (Invitrogen) using the BP clonase, and further
transferred to pRTRex using the LR clonase (Invitrogen).
(TIF)
Table S1 Expression values for genes showing significantly
different expression between cells with NDRG1 knock down
versus ectopic over-expression of NDRG1. Columns A–E show
symbol, name, Genbank Accession number, UniGene ID and
Agilent ID, respectively, for each of the genes. Columns F-AD
show the relative expression values in the cell populations
indicated (header row) compared to the expression in its respective
control. Log2 of the ratios of the colour intensity in the cells with
altered NDRG1 expression versus the controls are given.
(XLS)
Table S2 Enriched gene ontology terms indentified by GoMiner
analysis. Genes are listed alphabetically in the first column of the
table. The header row gives the name of the GO category, sorted
by increasing p-values. Categories with p-value above 0.005 are
excluded. (+) indicates association with a GO category.
(XLS)
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